1. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease:I. The 2014 diagnosis and staging working group report;Jagasia;Biol Blood Marrow Transplant,2015
2. Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels;Demirer;Bone Marrow Transplant,1996
3. Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels;Demirer;Bone Marrow Transplant,1996
4. Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation;Peccatori;Cancer,2005
5. Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience;De Giorgi;Ann Oncol,2005